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The objectives of this study were to evaluate the influence of cigarette smoking on gingival bleeding and serum concentrations of
cotinine, haptoglobin, and alpha 1-antitrypsin in Malaysian smokers. A total of 197 male smokers and nonsmokers were recruited
for this study. Plaque index, bleeding on probing (BOP), and levels of serum cotinine, haptoglobin, and alpha 1-antitrypsin were
evaluated. The data were analyzed using SPSS version 20.0, with the significance level set at 𝛼 ≤ 0.05. Linear regression analyses
were performed. The mean cigarette consumption per day was 13.39 ± 5.75 cigarettes; the mean duration was 16.03 ± 8.78 years.
Relatively low BOP values (26.05 ± 1.48) and moderate plaque indexes (51.35 ± 11.27) were found. The levels of serum cotinine
(106.9±30.71 ng/dL), haptoglobin (76.04 ± 52.48mg/dL), and alpha 1-antitrypsin (141.90 ± 18.40mg/dL) were significantly higher
in smokers compared to non-smokers. Multiple logistic regression models for all variables and smokers demonstrated observed
differences between BOP, the number of cigarettes per day, and duration of smoking, while serum cotinine, haptoglobin and
alpha-1 antitrypsin levels showed no significant differences. Duration of smoking (years) and the cotinine level in serum showed
a significant correlation with plaque index. The present analysis demonstrated that the duration of smoking in years, but not the
number of cigarettes smoked per day, was associated with reduced gingival bleeding in smokers.
1. Introduction
Numerous cross-sectional studies demonstrate increased
prevalence of periodontal disease among smokers [1–3].
Long-term prospective studies demonstrate that smoking
worsens the periodontal condition in smokers compared to
those who have quit smoking and to nonsmokers.
Cigarette addiction remains a harmful habit that facili-
tates the development and progression of periodontal dis-
eases, even when other contributory factors, such as oral
hygiene, plaque, calculus, and socioeconomic and demo-
graphic issues, are in check.The associated risk was estimated
with odds ratios of 2.5 to 6.0 [2, 4, 5]. The connection that
links smoking and periodontal diseases is based on the num-
ber of cigarettes. The probability for further attachment loss
varies from 2.05 for light smokers to 4.75 for heavy smokers.
This result conforms with the hypothetical idea that smoking
has increasing consequences on periodontal health [6].
Gingival bleeding upon probing (BOP) provides a quan-
titative indication of gingival/periodontal inflammation. A
longitudinal study into the association between BOP and loss
of attachment showed that bleeding on probing presents diag-
nostic predictability in treated patients. BOP is an indicator
for disease progression, but it is by no means definitive. Nev-
ertheless, it is a vital indicator in the assessment of the degree,
as well as the extent, of disease in a periodontal patient [7].
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Clinically, smokers presented with reduced signs of
inflammation compared to nonsmokers [8, 9].This result can
be due to the temporary gingival vasoconstriction induced
by nicotine. The swollen gingiva in smokers that exhibits
decreased vascular density and angiogenesis compared with
that of nonsmokers suggests a suppressed inflammatory
response that accounts for impaired wound healing [10].
Chronic smokers present with reduced gingival BOP, which
masks the clinical markers often used by dentists to monitor
periodontal health [8]. Traditionally, reduced bleeding in
smokers has been attributed to gingival vasoconstriction
induced by the actions of nicotine-stimulated adrenaline;
however, the available evidence that supports this hypothesis
in humans is not conclusive as smoking can cause vasodilata-
tion in some tissues due to the action of noradrenaline on A1-
adrenergic receptors. There is some evidence to support this
theory in animal models [3]. Serum cotinine concentrations
were chosen to test the hypothesis that nicotine (cotinine)
decreases gingival bleeding because of its vasoconstrictive
effects, which are mediated through norepinephrine. Many
components of cigarette smoke are able to alter the function
of immune cells [11, 12]. Acute phase reactants (APRs) are the
markers of inflammation, which are synthesized in response
to tissue damage and inflammation. During inflammation,
their concentrations increase one thousandfold over the
normal levels [11]. These markers are mainly produced
by hepatocytes, as well as by adipocytes, fibroblasts, and
endothelial cells. Similarly, the levels of cytokines and acute
phase proteins (APP) in plasma are due to tissue injury
and inflammatory conditions along with lower levels of all
mediators in healthy nonsmokers (HNS) versus smokers
(HS), signifying that these systemic inflammatory markers
changed in response to a threat by harmful materials from
smoking [12].
The concentration of cytokines and acute phase proteins
(APP) in plasma notably alters due to tissue injury, infection,
burn, shock, several types of inflammatory conditions, and
cancer. Smoking shows a relationship with acute phase
proteins similar to C-reactive protein (CRP) and fibrinogen
[13]. Smokers show increased levels of circulating leukocyte
counts and inflammatorymarkers, including CRP, intercellu-
lar adhesion molecule Type-1, interleukin (IL-6), E-selectin,
and P-selectin [14]. Alpha 1-antitrypsin (A1AT) is formed
in the liver, and it participates in protecting the lungs from
neutrophil elastase, a particular enzyme that is capable of dis-
rupting connective tissue. The normal blood levels for alpha
1-antitrypsin are within the range of 81–171mg/dL.This range
confers protection to tissues against enzymes of inflamma-
tory cells, particularly neutrophil elastase, although the con-
centration can increase upon acute inflammation. In smok-
ers, the levels of alpha 1-antitrypsin were exclusively and con-
siderably raised andwere related to the extent of smoking [15].
Haptoglobin is generated mainly by hepatocytes and
some other tissues, including the skin, lung, and kidney. The
normal range is 33–171mg/dL. As it is certainly an acute-
phase protein, any inflammatory condition linked to infec-
tion, extreme stress, burns, major crush injury, allergy, and so
forth will possibly boost the levels of plasma haptoglobin. In
smokers, the levels of haptoglobin increased with the degree
of smoking [16]. Haptoglobin and alpha 1-antitrypsin were
not previously evaluated in Malaysia’s smoker population.
We hypothesize that smoking is associated with decreased
gingival bleeding in a dose-dependent manner.The objective
of this study is to evaluate the influence of cigarette smoking
on gingival bleeding and on the serum concentrations of
haptoglobin and alpha 1-antitrypsin in selected Malaysian
smokers.
2. Materials and Methods
Convenience samples of 197 (99 smokers and 98 nonsmokers)
male patients were recruited for this study. They were either
patients or those accompanying them to the Primary Care
Unit (PCU), Faculty of Dentistry, at the University ofMalaya.
All participants were free of any systemic diseases, and they
were not on any medication for the last 6 months. Aspirin,
nonsteroidal anti-inflammatory, and nicotine replacement
medications were not used by the participants; bleeding
tendencies, such as vonWillebrand disease, were not assessed
in the participants. The mean age was 40.4 ± 12.0 (20–64)
years. The nature of the study was explained to all patients.
They were required to sign a written consent form prior to
the commencement of the study.
This study was in agreement with the ethical principles
of the World Medical Association’s Declaration of Helsinki
(1964). The study was approved by the Research and Ethical
Committee of the University of Malaya DF OP0701/0003(L).
The respondents were requested to fill out a questionnaire
with their health-related records as well as their history of
cigarette smoking.
The survey was completed independent of the medical
testing. The criteria used for the assessment of smoking
status were performed according to the criteria established
by the US Center for Disease Control and Prevention (CDC).
Current smokers were defined as those who had smoked over
100 cigarettes over their lifetime and who were smokers at
the time of the interview. Former smokers were those who
smoked over 100 cigarettes in their lifetime but were not
currently smokers, while nonsmokers were those who had
not smoked over 100 cigarettes in their lifetime [17].
All participants were examined by one calibrated expert
examiner. Fullmouth (except formolars) recording for visible
plaque index and bleeding on probing (BOP) introduced by
Ainamo and Bay was performed [18]. For the visible plaque
index, the patient was asked to rinse with plaque-disclosing
solution (Chrom-O-Red disclosing solution, Germiphene,
Brantford, ON, Canada) prior to recording. For BOP, all teeth
were air dried with the air syringe.
Intraoral examination was performed and WHO dental
probe was used to assess bleeding on probing and dental
plaque, and BOP was documented as absence or presence
(0/1). Bleeding was counted as a dichotomy of variables
at every location (present/absent). The manifestation of
bleeding in 10 seconds indicated a positive score that was
expressed as a percentage of the total number of gingival
margins examined. Intraexaminer calibrations performed on
plaque index (PLI) and bleeding on probing (BOP), 180 sites,
weremeasured on five patients, and the records were charted.
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Table 1: The mean standard, deviation, and 95% confidence intervals (CI) of the variables evaluated in the study in both smokers and non-
smokers.
Smokers Nonsmokers
𝑃 value S/NS
Patients number Mean ± SD 95% CI Patients number Mean ± SD 95% CI
Number of cigarettes per day 99 13.39 ± 5.75 12.25, 14.54 — — — — —
Duration of smoking per years 99 16.03 ± 8.78 12.92, 19.14 — — — — —
BOP 99 26.05 ± 1.48 23.09, 28.99 98 26.29 ± 17.219 −8.16, 7.58 0.941 NS
Plaque index 99 51.35 ± 11.27 47.35, 55.35 98 51.14 ± 18.64 −7.14, 7.72 0.939 NS
Cotinine (ng/dL) 99 106.9 ± 30.71 96.04, 117.82 98 19.20 ± 8.59 76.56, 98.97 0.000 S
Haptoglobin (mg/dL) 99 76.04 ± 52.48 57.24, 94.84 98 32.46 ± 6.30 24.66, 62.48 0.000 S
Alpha 1-antitrypsin (mg/dL) 99 141.90 ± 18.40 135.38, 148.43 98 123.57 ± 12.20 10.71, 25.97 0 .000 S
Table 2: Association between BOP and other variables.
Mean ± SD Patient number Pearson correlation 𝑃 value S/NS
Number of cigarettes per day 13.39 ± 5.75 99 0.323 0.001 S
Duration of smoking in years 16.03 ± 8.78 99 0.432 0.001 S
Cotinine (ng/dL) 106.9 ± 30.71 99 0.039 0.708 NS
Haptoglobin (mg/dL) 76.04 ± 52.48 99 0.144 0.155 NS
Alpha 1-antitrypsin (mg/dL) 141.90 ± 18.40 99 0.198 0.049 NS
One and a half hour following the initial measurements, the
examiner remeasured the same 180 sites, and the records were
charted. The charting was done again two times on the same
patients. Data were analyzed with SPSS and Cohen’s Kappa
coefficient. The result of the analysis was Kappa = 0.81 (𝑃 <
0.001), which showed almost perfect agreement [19].
A 10mL blood sample was obtained in a vacutainer
tube containing EDTA for analysis. All blood samples were
centrifuged, and the serum was aspirated in new tubes and
preserved in a refrigerator under −20∘C until being subjected
to laboratory analysis. The serum cotinine was analyzed by
the ELISA technique (ELISA Kit, Sigma Aldrich, USA). The
limit of detection and the upper limit for linearity for the
serum cotinine assay were 1 ng/mL and 500 ng/mL.
Haptoglobin and alpha 1-antitrypsin protein levels were
measured using the Beckman Coulter Image Immunochem-
istry System (Sigma Aldrich, USA). Clinical examination
and clinical parameters were recorded over several months;
additionally, the entire laboratory test was conducted over
two weeks.
3. Statistical Analysis
All analyses were performed with SPSS for Windows version
20.0 (Chicago Inc.). The significance level was set at 𝛼 ≤
0.05 with a 95% confidence interval. The obtained data were
checked for completion, and a double entry method was
used to ensure error-free data. Preliminary organization of
the data was performed, and the results were presented in
three steps. One step was the descriptive statistics of the study
subjects; the second step was the univariate correlation and
multiple linear regression model. The data were summarized
using means, corresponding standard deviations and 95%
confidence intervals. The independent 𝑡-test was used to
compare smokers and nonsmokers. A scatter plot correlation
analysis was employed to test the association between the
outcome variables and the predictor variables. Variables
that are significant at 5% were identified and included in
the final regression model. Linear regression analysis was
performed for BOP and the PI, and the respective variables
were significant after bivariate analysis.
4. Results
A total of 197 male smoker and nonsmoker patients par-
ticipated in this study. There were 23640 sites examined to
assess the visible plaque index and bleeding on probing.
Table 1 gives an overview of the means, standard deviations,
and 95% confidence intervals (CI) of the variables evaluated
in this study. The mean cigarette consumption per day was
13.39 ± 5.75 sticks; the mean duration was 16.03 ± 8.78 years.
Smokers demonstrated a relatively low mean bleeding index
of 26.05 ± 1.48 and a higher plaque index of 51.35 ± 11.27
compares to nonsmokers, 26.29 ± 17.219 and 51.14 ± 18.64.
Statistical analysis revealed nonsignificant deference.𝑃 values
were 0.941 and 0.939, respectively.
The serum cotinine level in smokers was 106.9 ± 30.71,
relatively the same level as that found in smoker by previous
researches and higher than that found in nonsmokers, 19.20±
8.59. Statistical analysis demonstrated significant deference.
𝑃 value was 0.000.
Haptoglobin and alpha 1-antitrypsin (76.04 ± 52.48 and
141.90 ± 18.40mg/dL) showed higher means than those
evaluated in nonsmokers. Statistical analysis demonstrated
high significant deference. 𝑃 value was 0.000.
Table 2 represents the association between BOP and
other variables. In a preliminary main effect multiple logistic
regression model for all variables and smoker subjects, the
only significant differences were found between BOP and
the number of cigarettes per day and between BOP and the
duration of smoking (years) where 𝑃 value was 0.001, while
the serum cotinine, haptoglobin, and alpha 1-antitrypsin
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Table 3: Regression analysis of BOP and factors significant at the univariate level; only duration of smoking is significantly related to BOP at
regression analysis.
Model Beta 𝑃 value 95% CI S/NS
Constant — 0.552 −15.147, 28.175
Number of cigarettes per day 0.104 0.361 −0.312, 0.848 NS
Duration of smoking in years 0.352 0.004 −0.200, 0.99799 S
Alpha 1-antitrypsin mg/dL 0.055 0.575 −0.113, 0.202 NS
Table 4: Correlation between plaque index and smoking variables.
Mean ± SD Patient number Pearson correlation 𝑃 value S/NS
Number of cigarettes per day 13.39 ± 5.75 99 0.017 0.870 NS
Duration of smoking in years 16.03 ± 8.78 99 0.366 0.001 S
Cotinine (ng/dL) 106.9 ± 30.71 99 0.263 0.008 S
Haptoglobin (mg/dL) 76.04 ± 52.48 99 0.137 0.178 NS
Alpha 1-antitrypsin (mg/dL) 141.90 ± 18.40 99 0.196 0.052 NS
levels showed no significant differences where 𝑃 values were
0.039, 0.144, 0.198, respectively. However, smoking was neg-
atively associated with gingival bleeding; only the duration
of smoking was significantly related to BOP at regression
analysis as 𝑃 value was 0.004 (Table 3).
Table 4 shows a correlation between plaque index and
smoking variables. A nonsignificant correlation was found
between the number of cigarettes per day and the haptoglobin
and alpha 1-antitrypsin levels where 𝑃 values were 0.870,
0.178, and 0.052, respectively, while the duration of smoking
(years) and the cotinine level in serum showed a significant
correlation to plaque index where 𝑃 values were 0.001 and
0.001, respectively. Regression analysis for plaque index and
factors revealed significant differences for the duration of
smoking (years) and the cotinine level 𝑃 values were 0.001
for both (Table 5).
5. Discussion
Cotinine is the preferred serum biomarker for tobacco
exposure; its levels can be used as an objective, reliable
and quantitative method to evaluate the role of smoking in
inflammatory periodontal disease [20].
Both local and systemic effects of cigarette smoking on
periodontal diseases have been suggested [21, 22]. Gingi-
val bleeding and vascular hyperemic reactions linked with
plaque-induced gingivitis are reduced in smokers.The differ-
ence in bleeding responses between smokers andnonsmokers
has generally been attributed to the vasoconstrictive proper-
ties of nicotine [23, 24].
The main purpose of the current study is to examine
the relationship between cigarette smokers and overt signs
of gingival inflammation, such as bleeding upon probing, in,
otherwise, healthy smokers. For this reason, patient selection
was based largely on the extent of the smoking status and it
did not consider the periodontal status of the patients as a
number of earlier studies [10, 25] selected patients who were
diagnosed with gingival inflammation. This assortment was
mostly chosen to evaluate the relationship between smoking
and gingival bleeding and to enhance understanding about
the connection of smoking to gingival bleeding.The period of
smoking in these cases ranged from 5 to 33 years, which was
afterwards computed into pack years. However, some earlier
studies [3, 26] classified people who had quit smoking for
approximately 2 to 5 years or more under the nonsmokers
group. It was decided in this study to exclude former smokers
to eliminate any long-term effects of smoking on periodontal
tissues. Females were purposely excluded from the study
because it is difficult to recruit females who admit that they
smoke.The second rationale for not including females was to
avoid potential hormone-induced microcirculatory changes
[27].
Smokers demonstrated a relatively low mean bleeding
index, a higher plaque index, and high cotinine, alpha 1-
antitrypsin, and haptoglobin levels compared to nonsmokers,
possibly due to the local and systemic effects of smoking on
these parameters [8, 9, 14].
The oral hygiene status, as represented by plaque scores,
for smokers was 51.35 ± 11.27, and regression analyses
demonstrated a significant relationship between plaque score,
duration of smoking (years), and serum cotinine.This finding
is in accordance with earlier studies [3, 28, 29]. However,
other studies showed higher plaque levels in smokers [30,
31], while some studies demonstrated less plaque levels in
smokers [32, 33]. In the present analysis, the results showed
that gingival bleeding was not affected by the number of
cigarettes smoked per day. The findings of our study do not
appear to support the fact that the number of cigarettes per
day suppresses gingival bleeding (Table 3). These findings
were in disagreement with the results of several studies [9,
34]. Only the duration of smoking in years suppressed the
effect on gingival bleeding upon gentle probing (−0.200 and
0.997).
The relationship between smoking and gingival bleeding
appears to be dose dependent.Themean number of cigarettes
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Table 5: Regression analysis for plaque index and factors.
Model Beta 𝑃 value 95% CI S/NS
Constant — 0.001 48.703, 63.633
Duration of smoking in years 0.438 0.001 0.333, 0.792 S
Cotinine (ng/dL) −0.353 0.001 −0.195, −0.064 S
All of the variables are significant and protective.
smoked daily was 13.39. This result is in concurrence with
earlier studies that investigated the dose-response function
among current smokers [24]. The present data suggest that
lifetime exposure to smoking exerts an effect on reducing
bleeding on probing. This work is in agreement with pre-
vious studies [7, 35] that demonstrated reduced gingival
bleeding in relation to duration in years. The mechanisms
by which smoking suppresses gingival bleeding are not well
understood. Usually, decreased bleeding in smokers is linked
to gingival vasoconstriction aggravated by the effects of
nicotine-stimulated adrenaline, as well as noradrenaline, on
𝛼1-adrenergic receptors.
Smoking has profound consequences on the immune and
inflammatory systems [36]. Smoking has adverse effects on
fibroblast function [37], chemotaxis, and phagocytosis by
neutrophils [38] and immunoglobulin production [39].
Tissue injury occurs mainly due to oxidative stress and
also indirectly through the activation of redox-sensitive
gene transcription factors, such as nuclear factor-kappa beta
[30], which subsequently navigates downstream proinflam-
matory cytokine/chemokine production [40]. The resultant
periodontal inflammation creates a low-grade inflammatory
response that is detectable within the peripheral vasculature
[41].
The evaluation of serum acute phase proteins may help
in identifying patients who are at high risk for destructive
disease or reveal those patients who are undergoing a process
of periodontal breakdown. An increasing number of studies
are focusing on the relationship between C-reactive protein
and periodontitis. A high plasma level of this protein was
observed in patients with severe periodontitis in comparison
to the healthy group [42]. Our results showed no signif-
icant relationship of haptoglobin and alpha 1-antitrypsin
with smoking duration, bleeding on probing, plaque index,
and cigarette consumption per day. On the basis of the
observation that smokers may present with a lower level
of gingival inflammation, it has been speculated that the
gingival blood flow in smokers may be less in comparison to
nonsmokers [8, 10]. This would also induce a decreased local
host response. So, smoking is thought mainly to affect the
periodontal tissues byway of the vascular and immunological
response of the body. The demonstration of correlations
of levels of immunosuppressive acute phase proteins with
smoking extent and age among normal subjects suggests
that changes in the levels of these proteins may be related
etiologically to the association of smoking [15]. Further study
is required to evaluate the significance of bleeding on probing
before and after nonsurgical treatment in smokers.
6. Conclusions
In conclusion, the present analysis demonstrated that the
duration of smoking in years was associated with reduced
gingival bleeding and plaque formation in smokers; hap-
toglobin and alpha 1-antitrypsin levels were higher in smok-
ers. The cotinine level in serum showed a significant correla-
tion with plaque index.
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